Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 57 clinical trials
Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging

Background: During the repair process of deep venous thrombosis, capillary formation is seen from day 18 to day 25. Contrast agent investigation is well known to detect small vessels in arterial disease. We intend to use this method to detect early vascularisation in the thrombus, in order to get more …

acute deep venous thrombosis
deep vein thrombosis
venous thrombosis
  • 10 views
  • 07 Nov, 2020
  • 1 location
Computerized Registry of Patients With Venous Thromboembolism (RIETE)

, patients with contraindications to anticoagulation therapy, extreme body weight, etc), with the purpose of decreasing mortality, frequency of thromboembolic recurrences as well as bleeding complications

clot
cancer
thrombosis
pulmonary embolism
anticoagulation therapy
  • 6 views
  • 27 Jan, 2021
  • 197 locations
Post-approval Study of Percutaneous Left Atrial Appendage Closure ( FLAAC-2 )

atrial fibrillation in whom long term anticoagulation therapy cannot be conducted. This procedure involves implantation of an occlusion device into the left atrial appendage to close it and prevent

stroke
anticoagulants
left atrial appendage closure
anticoagulant therapy
anticoagulation therapy
  • 3 views
  • 23 Jan, 2021
Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK

A novel Coronavirus (COVID-19) infection leading to pneumonia and severe acute respiratory failure [acute respiratory distress syndrome (ARDS)] and death is a global threat. On 11/03/2020, WHO declared the Covid-19 outbreak a global pandemic. As of 18th of March, there are 202,309 confirmed cases with 8,013 deaths. Patients with severe …

clot
prothrombin
venous thromboembolism
d-dimer
thromboembolism
  • 0 views
  • 25 Jan, 2021
  • 1 location
START-Register: Survey on Anticoagulated Patients Register

This is a phase 4 cohort prospective, open, national, multicentre study that collects data on history of patients treated chronically with anticoagulant drugs, including the novel direct oral anticoagulants (DOACs). The Registry is designed solely for observational purposes and is not intended to have any influence on the treatment of …

anticoagulants
vitamin k antagonist
vitamin k
  • 0 views
  • 23 Jan, 2021
WHITE Study: WHIch Decision After a First Venous ThromboEmbolism?

The WHITE study is a multicenter, multinational, investigators-initiated, observational, prospective study conducted in a consecutive series of ambulatory patients who had completed the recommended or practicable period of anticoagulation after a first-ever episode of venous thromboembolism (VTE) The general aim of the study is to evaluate the distribution of decisions …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

This study aims to compare the effectiveness and safety regarding treatment with standard anticoagulant only or adding antiplatelet to anticoagulant in patients with non-valvular atrial fibrillation and significant atherosclerosis including extracranial, intracranial, coronary or peripheral artery.

  • 0 views
  • 23 Jan, 2021
  • 1 location
Registry of Patients Prescribed Anticoagulation

The Gonda Vascular Center- Thrombophilia Clinic at Mayo Clinic in Rochester, Minnesota utilizes a standardized, guideline-directed, yet patient-oriented approach for treating patients diagnosed with venous thromboembolism (VTE).This study is the ongoing registry of clinical practice with standardized approach to patient assessment and therapy. As most of registries it does not …

  • 17 views
  • 25 Jan, 2021
  • 1 location
Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation

To estimate the prevalence of iron deficiency (ID) in patients with atrial fibrillation

diagnostic procedure
fibrillation
ejection fraction
  • 22 views
  • 26 Jan, 2021
  • 1 location
What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.

The optimal antithrombotic therapy for patients with atrial fibrillation (AF) with a CHA2DS2-VASc score 1 with concomitant acute coronary syndrome (ACS) or revascularisation by percutaneous coronary intervention (PCI) with stenting, is still unknown. For these patients current North American and European guidelines recommend a triple therapy strategy, including vitamin K …

atrial fibrillation
coronary artery bypass graft
anticoagulant therapy
clopidogrel
anticoagulants
  • 2 views
  • 23 Jan, 2021
  • 10 locations